BIO-key International Inc. (NASDAQ:BKYI) Short Interest Down 75.8% in February

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 310,850 shares, a drop of 75.8% from the January 29th total of 1,284,522 shares. Approximately 3.0% of the company’s shares are sold short. Based on an average trading volume of 357,109 shares, the days-to-cover ratio is currently 0.9 days. Based on an average trading volume of 357,109 shares, the days-to-cover ratio is currently 0.9 days. Approximately 3.0% of the company’s shares are sold short.

BIO-key International Trading Up 1.1%

BKYI traded up $0.01 on Friday, reaching $0.65. 111,590 shares of the company traded hands, compared to its average volume of 4,917,199. The company has a market cap of $7.00 million, a P/E ratio of -0.62 and a beta of 0.41. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. BIO-key International has a one year low of $0.51 and a one year high of $1.97. The firm has a fifty day simple moving average of $0.61 and a two-hundred day simple moving average of $0.72.

Institutional Inflows and Outflows

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC raised its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 26.51% of the company’s stock.

Analyst Ratings Changes

BKYI has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.